R. -awad, D. Levac, P. Cybulska, Z. Merali, V. Trudeau et al., Effects of traditionally used anxiolytic botanicals on enzymes of the ??-aminobutyric acid (GABA) systemThis article is one of a selection of papers published in this special issue (part 1 of 2) on the Safety and Efficacy of Natural Health Products., Canadian Journal of Physiology and Pharmacology, vol.327, issue.9, pp.933-942, 2007.
DOI : 10.1213/01.ANE.0000096189.70405.A5

R. Balz, Les Huiles essentielles et comment les utiliser. Eygluy-l'Escoulin, 1996.

D. Baudoux, L'aromathérapie ? Se soigner par les huiles essentielles. Editions Amyris, 2008.

K. Baxter, P. Cbent, S. Padula, A. Moore, D. Patterson et al., Stockley's Drug Interactions. 10 ème édition Valerian for sleep : a systematic review and meta-analysis. The american journal of medicine, pp.1005-1012, 2006.

V. -bernades-genisson, J. Bernadou, I. Berque-bestel, J. Brion, and O. Duval, Enguehard- Gueiffier C. Médicaments actifs sur le système nerveux central, 2011.

S. Boukris, Ces médicaments qui nous rendent malades. Le Cherche Midi, 2009.

C. -braestrup and R. Squires, Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding., Proceedings of the National Academy of Sciences, vol.74, issue.9, pp.3805-3809, 1977.
DOI : 10.1073/pnas.74.9.3805

J. -bruneton, Phytothérapie : Les données de l'évaluation. Lavoisier, 2002.

-. , S. Stewart, and S. , Cognitive and sedative effects of benzodiazepine use, Current pharmaceutical design, vol.8, issue.1, pp.45-58, 2002.

J. Bussell, The effect of acupuncture on working memory and anxiety Journal of acupuncture and meridians studies, pp.241-246, 2013.

J. -calop, S. Limat, C. Fernandez, and G. Aulagner, Pharmacie clinique et thérapeutique. 4 ème édition, 2012.

C. -caulin, Vidal Recos recommandations en pratique 2016, 2015.

F. -chapelle, B. Monié, . Poinsot-robin, . Stéphane-rusinek, and M. Willard, Aide-Mémoire Thérapies comportementales et cognitives. 2 ème édition, 2014.

B. -cooke and E. Ernst, Aromatherapy : a systematic review, The British Journal of General Practice, vol.50, issue.455, pp.493-496, 2000.

J. -cottin, A. Gouraud, M. Jean-pastor, A. Dautriche, C. Boulay et al., Safety profile of etifoxine: A French pharmacovigilance survey, Fundamental & Clinical Pharmacology, vol.21, issue.2, pp.147-152, 2016.
DOI : 10.1002/pds.3333

H. -curran, Tranquillising memories: A review of the effects of benzodiazepines on human memory, Biological Psychology, vol.23, issue.2, pp.179-213, 1986.
DOI : 10.1016/0301-0511(86)90081-5

S. -dahmer and E. Scott, Health effects of hawthorn, American family physician, vol.81, issue.4, pp.465-468, 2010.

J. -delay and P. Deniker, Caractéristiques psycho-physiologiques des médicaments neuroleptiques, 1957.

C. Dennehy, C. Tsourounis, and A. Horn, Dietary supplement-related adverse events reported to the California Poison Control System, American Journal of Health-System Pharmacy, vol.62, issue.14, pp.62-1476, 2005.
DOI : 10.2146/ajhp040412

K. -dhawan, S. Dhawan, and A. Sharma, Passiflora: a review update, Journal of Ethnopharmacology, vol.94, issue.1, pp.1-23, 2004.
DOI : 10.1016/j.jep.2004.02.023

K. -dhawan, S. Kumar, and A. Sharma, Anxiolytic activity of aerial and underground parts of Passiflora incarnata, Fitoterapia, vol.72, issue.8, pp.922-926, 2001.
DOI : 10.1016/S0367-326X(01)00322-7

J. Dousset, Histoire des médicaments, des origines à nos jours. Ovadia, 2010.

G. -farrer-halls, La bible de l'aromathérapie et des huiles essentielles. 2 ème édition. Guy Trédaniel éditeur, 2010.

J. -fastbom, Y. Forsell, and B. Winblad, Benzodiazepines May Have Protective Effects Against Alzheimer Disease, Alzheimer Disease & Associated Disorders, vol.12, issue.1, pp.14-17, 1998.
DOI : 10.1097/00002093-199803000-00002

C. Caldentey and G. Flores-mateo, Effectiveness of Valerian on insomnia : a meta-analysis of randomized placebo-controlled trials, Sleep medicine, vol.11, issue.6, pp.505-511, 2010.

P. -fisher and A. Ward, Medicine in Europe: Complementary medicine in Europe, BMJ, vol.309, issue.6947, pp.107-111, 1994.
DOI : 10.1136/bmj.309.6947.107

C. -fortin and R. Rousseau, Psychologie cognitive : une approche de traitement de l'information. Presses de l, 2011.

M. Ghoneim and S. Mewaldt, Benzodiazepines and human memory : a review, Anesthesiology, vol.72, issue.5, pp.926-938, 1990.

N. -grosjean, Le grand livre de l'aromathérapie. Eyrolles, 2013.

O. Grundmann, J. Wang, G. Mcgregor, and V. Butterweck, Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system, Planta Medica, issue.15, pp.74-1769, 2008.

G. -guaiana, C. Barbui, and A. Cipriani, Hydroxyzine for generalised anxiety disorder. The Cochrane database of systematic reviews, 2010.

A. -hamon, A. Morel, B. Hue, M. Verleye, and J. Gillardin, The modulatory effects of the anxiolytic etifoxine on GABA-A receptors are mediated by the ? subunit, Neuropharmacology, pp.45-293, 2003.

D. Healy, Les médicaments psychiatriques démystifiés, 2009.

A. Heather, Benzodiazepine withdrawal : outcome in 50 Patients, British Journal of Addiction, vol.82, issue.6, pp.655-671, 1987.

A. Heather, The diagnosis and management of benzodiazepine dependence, Current Opinion in Psychiatry, vol.18, issue.3, pp.249-255, 2005.

S. Hood, A. Norman, D. Hince, J. Melichar, and G. Hulse, Benzodiazepine dependence and its treatment with low dose flumazenil, British Journal of Clinical Pharmacology, vol.2, issue.3, pp.285-294, 2014.
DOI : 10.1016/0028-3908(92)90180-W

URL : http://onlinelibrary.wiley.com/doi/10.1111/bcp.12023/pdf

A. Ibarra, N. Feuillere, M. Roller, E. Lesburgere, and D. Beracochea, Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice, Phytomedicine, vol.17, issue.6, pp.17-397, 2010.
DOI : 10.1016/j.phymed.2010.01.012

P. -imfeld, M. Bodmer, S. Jick, and C. Meier, Benzodiazepine Use and Risk of Developing Alzheimer???s Disease or Vascular Dementia: A Case???Control Analysis, Drug Safety, vol.3, issue.10, pp.38-909, 2015.
DOI : 10.1517/14740338.3.5.485

K. -janhsen, P. Roser, and K. Hoffmann, The problems of long-term treatment with benzodiazepines and related substances, Deutsches Ärzteblatth International, vol.112, issue.12, pp.1-7, 2015.

T. Kaptchuk, Acupuncture : theory, efficacy, and practice. Annals of internal medicines, pp.374-383, 2002.
DOI : 10.7326/0003-4819-136-5-200203050-00010

S. -khom, I. Baburin, E. Timin, A. Hohaus, G. Trauner et al., Valerenic acid potentiates and inhibits GABAA receptors: Molecular mechanism and subunit specificity, Neuropharmacology, vol.53, issue.1, pp.178-187, 2007.
DOI : 10.1016/j.neuropharm.2007.04.018

M. -lader, Benzodiazepine harm: how can it be reduced?, British Journal of Clinical Pharmacology, vol.66, issue.Suppl 2, pp.295-301, 2014.
DOI : 10.2165/0023210-200923010-00002

R. -lagnaoui, B. Begaud, N. Moore, A. Chaslerie, A. Fourrier et al., Benzodiazepine use and risk of dementia : a nested case-control study, Journal of clinical epidemiology, issue.3, pp.55-314, 2002.

R. -lagnaoui, M. Tournier, Y. Moride, C. Wolfson, T. Ducruet et al., The risk of cognitive impairment in older community-dwelling women after benzodiazepine use, Age and Ageing, vol.38, issue.2, pp.226-228, 2009.
DOI : 10.1093/ageing/afn277

Y. Landry and J. Gles, Pharmacologie des cibles à la thérapeutique

R. -mathie, Controlled clinical studies of homeopathy, Homeopathy, vol.104, issue.4, pp.328-332, 2015.
DOI : 10.1016/j.homp.2015.05.003

D. -megglé, Les thérapies brèves des méthodes efficaces qui bouleversent la psychothérapie. Presses de la Renaissance, 2002.

L. Miyasaka, A. Atallah, and B. Soares, Valerian for anxiety disorders. The Cochrane database of systematic reviews, 2006.
DOI : 10.1002/14651858.cd004515.pub2

H. -mohler and T. Okada, Benzodiazepine receptor: demonstration in the central nervous system, Science, vol.71, issue.12, pp.849-851, 1977.
DOI : 10.1073/pnas.71.12.4802

A. -movafegh, R. Alizadeh, F. Hajimohamadi, F. Esfehani, and M. Nejatfar, Preoperative Oral Passiflora Incarnata Reduces Anxiety in Ambulatory Surgery Patients: A Double-Blind, Placebo-Controlled Study, Anesthesia & Analgesia, vol.106, issue.6, pp.1728-1732, 2008.
DOI : 10.1213/ane.0b013e318172c3f9

N. -nguyen, E. Fakra, V. Pradel, E. Jouve, A. Alquier et al., Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice, Human Psychopharmacology: Clinical and Experimental, vol.44, issue.3, pp.139-149, 2006.
DOI : 10.1001/archpsyc.1976.01770090101010

C. Ollier, Le conseil en phytothérapie, 2011.

J. Pato?ka and J. Jakl, Biomedically relevant chemical constituents of Valeriana officinalis, Journal of Applied Biomedicine, vol.8, issue.1, pp.11-18, 2010.
DOI : 10.2478/v10136-009-0002-z

P. Petit, Précis de psychopharmacologie médicale. Sauramps Medical, 2011.

H. -pétursson, The benzodiazepine withdrawal syndrome, Addiction, vol.39, issue.11, pp.1455-1459, 1994.
DOI : 10.1176/ajp.141.11.1427

A. -quemoun, S. H. Pensa, M. M. Dale, J. M. Ritter, R. J. Flower et al., Ma bible de l'homéopathie. Quotidien malin éditions Rang's and Dale's Pharmacology. 7 ème édition, 2012.

F. -rashidi-fakari, M. Tabatabaeichehr, and H. Mortazavi, The effect of aromatherapy by essential oil of orange on anxiety during labor : A randomized clinical trial, Iranian journal of nursing and midwifery research, vol.20, issue.6, pp.661-664, 2015.

-. , W. Griffin, M. Schaffner, W. Baugh, D. Melton et al., Psychotropic drug use and the risk of hip fracture, The New England journal of medicine, issue.7, pp.316-363, 1987.

J. -raynaud, Prescription et conseil en Phytothérapie, 2005.

N. Selloum and S. Faure, Du mécanisme d'action des médicaments à la thérapeutique, 2015.

. Benzodiazepine, psychotropic medication, and dementia : A population-based cohort study Alzheimer's & Dementia, pp.604-613

A. Shakeri, A. Sahebkar, and B. Javadi, Melissa officinalis L. ??? A review of its traditional uses, phytochemistry and pharmacology, Journal of Ethnopharmacology, vol.188, pp.204-228, 2016.
DOI : 10.1016/j.jep.2016.05.010

J. Shergis, X. Ni, M. Jackson, A. Zhang, X. Guo et al., A systematic review of acupuncture for sleep quality in people with insomnia, Complementary Therapies in Medicine, vol.26, pp.11-20, 2016.
DOI : 10.1016/j.ctim.2016.02.007

D. Stein, Etifoxine Versus Alprazolam for the Treatment of Adjustment Disorder with Anxiety: a Randomized Controlled Trial, Advances in Therapy, vol.64, issue.1, pp.57-68, 2015.
DOI : 10.2466/pr0.1989.64.1.51

S. Stewart, The effects of benzodiazepines on cognition, Journal of clinical psychiatry, vol.66, issue.2, pp.9-13, 2005.

A. Taiwo, F. Leite, G. Lucena, M. Barros, D. Silveira et al., Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats : Influence of administration and gender, Indian Journal of Pharmacology, vol.44, issue.2, pp.189-192, 2012.

M. -talbert, G. Willoquet, and R. Gervais, Guide Pharmaco Clinique

P. Tassi, A. Thibault-stoll, S. Chassagnon, S. Biry, and C. Petiau, Th??rapie comportementale et cognitive de l???insomnie, Journal de Th??rapie Comportementale et Cognitive, vol.20, issue.4, pp.125-130, 2010.
DOI : 10.1016/j.jtcc.2010.09.017

S. Verma, V. Jain, D. Verma, and R. Khamesra, Crataegus oxyacantha a cardioprotective herb, Journal of herbal medicine and toxicology, vol.1, issue.1, pp.65-71, 2007.

C. Vinkers and B. Olivier, Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators?, Advances in Pharmacological Sciences, vol.57, issue.2, pp.10-1155, 2012.
DOI : 10.1016/S0376-8716(00)00123-X

-. Durand, D. Le-jeunne, and C. , Dorosz Guide pratique des médicaments 2016. 35 ème édition. Maloine, 2015.

W. Williams, D. Mclin, M. Dressman, and D. Neubauer, Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol.234, issue.9, pp.36-1028, 2016.
DOI : 10.1620/tjem.234.123

C. Wu, T. Ting, S. Wang, I. Chang, and K. Lin, Effect of benzodiazepine discontinuation on dementia risk. The American journal of geriatry psychiatry, pp.151-159, 2011.
DOI : 10.1097/jgp.0b013e3181e049ca

C. Wu, S. Wang, I. Chang, and K. Lin, The association between dementia and longterm use of benzodiazepine in the elderly : nested case-control study using claims data. The American journal of geriatry psychiatry, pp.17-614, 2009.

J. Zahalka, Les huiles essentielles : 230 huiles essentielles 170 maux traités. Editions Dauphin, 2010.

P. -zanoli, R. Avallone, and M. Baraldi, Behavioral characterisation of the flavonoids apigenin and chrysin, Fitoterapia, vol.71, issue.1, pp.117-123, 2000.
DOI : 10.1016/S0367-326X(00)00186-6